PT1395231E - Preparacao para a remocao de material queratinoso anormal - Google Patents

Preparacao para a remocao de material queratinoso anormal

Info

Publication number
PT1395231E
PT1395231E PT02732724T PT02732724T PT1395231E PT 1395231 E PT1395231 E PT 1395231E PT 02732724 T PT02732724 T PT 02732724T PT 02732724 T PT02732724 T PT 02732724T PT 1395231 E PT1395231 E PT 1395231E
Authority
PT
Portugal
Prior art keywords
removal
abnormal
keratinosus
preparation
water
Prior art date
Application number
PT02732724T
Other languages
English (en)
Inventor
Horst Ulbricht
Pooth Rainer
Shuster Samuel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT1395231E publication Critical patent/PT1395231E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT02732724T 2001-05-30 2002-05-17 Preparacao para a remocao de material queratinoso anormal PT1395231E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10126501A DE10126501A1 (de) 2001-05-30 2001-05-30 Zubereitung zur Entfernung von abnormen Keratinmaterial

Publications (1)

Publication Number Publication Date
PT1395231E true PT1395231E (pt) 2005-08-31

Family

ID=7686754

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02732724T PT1395231E (pt) 2001-05-30 2002-05-17 Preparacao para a remocao de material queratinoso anormal

Country Status (11)

Country Link
US (2) US20020197291A1 (pt)
EP (1) EP1395231B1 (pt)
JP (1) JP4359140B2 (pt)
AT (1) ATE296607T1 (pt)
CA (1) CA2448829C (pt)
DE (2) DE10126501A1 (pt)
DK (1) DK1395231T3 (pt)
ES (1) ES2242027T3 (pt)
MX (1) MXPA03009984A (pt)
PT (1) PT1395231E (pt)
WO (1) WO2002098380A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3157101A (en) * 2000-01-03 2001-07-16 Manfred Bohn Preparations for the non-traumatic excision of a nail
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
US20060216260A1 (en) * 2003-04-24 2006-09-28 L'oreal Cosmetic peeling method using urea
US20070166249A1 (en) * 2003-08-25 2007-07-19 Hans Meyer Pharmaceutical and cosmetic formulations for treating fingernails
DE102006049586A1 (de) * 2006-10-22 2008-04-24 Rudy Susilo Nagellackenferner für kosmetische und medizinische Anwendungen
US8293174B2 (en) * 2007-10-17 2012-10-23 American Sterilizer Company Prion deactivating composition and methods of using same
US20090191138A1 (en) * 2008-01-30 2009-07-30 Mediquest Therapeutics, Inc. Novel topical formulations for improving the appearance of nails
NL1035426C2 (nl) * 2008-05-15 2009-11-17 Atp Marketing & Promotion Ag Farmaceutische samenstellingen voor de behandeling van wratten.
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
KR101055963B1 (ko) * 2008-12-01 2011-08-11 (주)더페이스샵 각질 박리 촉진용 화장료 조성물
WO2012110430A1 (en) * 2011-02-10 2012-08-23 Moberg Derma Ab Novel composition for topical use on a nail
US8673279B2 (en) * 2011-08-31 2014-03-18 Avon Products, Inc. Cosmetic liquid extractor comprising nonionic polymers
AU2015201680B2 (en) * 2015-04-01 2016-12-22 Neat Feat Products Limited Urea based skin treatment
US9770609B2 (en) 2015-04-01 2017-09-26 Neat Feat Products Limited Urea based skin treatment

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402935A (en) * 1981-04-16 1983-09-06 Del Laboratories, Inc. Moisturizing nail polish composition
DE3520098A1 (de) * 1985-06-05 1986-12-11 Bayer Ag, 5090 Leverkusen Azolderivate enthaltende formulierungen sowie ihre verwendung zur atraumatischen nagelentfernung
AU599064B2 (en) 1985-11-04 1990-07-12 Dermatological Products Of Texas Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
FR2613227B1 (fr) 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5098421A (en) * 1989-10-16 1992-03-24 Zook Gerald P Viscoelastic gel foot padding and medicating device
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
US5460620A (en) * 1992-07-31 1995-10-24 Creative Products Resource, Inc. Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5639740A (en) * 1995-03-10 1997-06-17 Crandall; Wilson Trafton Topical moisturizing composition and method
US5834513A (en) * 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5993790A (en) * 1997-08-04 1999-11-30 Pedinol Pharmacal Inc. Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections
US5919470A (en) * 1998-04-02 1999-07-06 Bradley Pharmaceuticals, Inc. Dermatological composition
AU3157101A (en) 2000-01-03 2001-07-16 Manfred Bohn Preparations for the non-traumatic excision of a nail
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US6753071B1 (en) * 2001-09-27 2004-06-22 Advanced Cardiovascular Systems, Inc. Rate-reducing membrane for release of an agent
US6495602B1 (en) * 2001-12-13 2002-12-17 Bradley Pharmaceuticals, Inc. Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
US6673842B2 (en) * 2002-03-20 2004-01-06 Bradley Pharmaceuticals, Inc. Method of treating onychomycosis
US6743417B2 (en) * 2002-04-22 2004-06-01 Bradley Pharmaceuticals, Inc. Method of treating onychomycosis with urea and an antioxidant
US6573301B1 (en) * 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use

Also Published As

Publication number Publication date
MXPA03009984A (es) 2004-02-12
US20040146555A1 (en) 2004-07-29
JP2004532268A (ja) 2004-10-21
JP4359140B2 (ja) 2009-11-04
DE10126501A1 (de) 2002-12-12
ES2242027T3 (es) 2005-11-01
EP1395231B1 (de) 2005-06-01
EP1395231A1 (de) 2004-03-10
DE50203283D1 (de) 2005-07-07
ATE296607T1 (de) 2005-06-15
DK1395231T3 (da) 2005-09-12
CA2448829A1 (en) 2002-12-12
CA2448829C (en) 2010-04-20
US20020197291A1 (en) 2002-12-26
US7476396B2 (en) 2009-01-13
WO2002098380A1 (de) 2002-12-12

Similar Documents

Publication Publication Date Title
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
PT1395231E (pt) Preparacao para a remocao de material queratinoso anormal
HUP0101176A3 (en) Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases, process for their preparation and pharmaceutical compositions containing them
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
IS2156B (is) Settar bensensúlfonamíðafleiður sem forlyf fyrir COX-2 tálma, aðferð til þess að búa þær til, lyfjasamsetningar sem innihalda þær og notkun þeirra við framleiðslu lyfja
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
HUP0401192A3 (en) Use of photosenzitizing agent for preparation ot, of pharmaceutical composition for treating wounds
ATE366568T1 (de) Aerosolformulierungen von salmeterol xinafoate
AR025788A1 (es) COMPOSICIONES HERBICIDAS SELECTIVAS, SU EMPLEO PARA LA LUCHA CONTRA PLANTAS INDESEABLES, PROCEDIMENTO PARA LA LUCHA CONTRA PLANTAS INDESEABLES Y PROCEDIMENTO PARA LA PREPARACIoN DE ESAS COMPOSICIONES.
AU2002365516A1 (en) Benzamide derivatives, processes for their preparation, and their pharmaceutical use
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
WO2004069138A3 (en) Pharmaceutical formulation
BR0211063A (pt) Sais de derivados anticonvulsivantes
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
EA200600603A1 (ru) Оральная система доставки лекарственного препарата
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
PT1223972E (pt) Suspensao de uma proteina de epi-hne processo para a sua preparacao aerossol de po anidro derivado dela composicoes farmaceuticas contendo a referida suspensao ou aerossol e as suas utilizacoes
HUP0203212A3 (en) Integrin inhibitors, process for preparation thereof, their use preparation of pharmaceutical compositions and the compositions
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen
PT1408035E (pt) Metodo de preparacao de derivativos de 1.5-diaril-3-trifluorometilo-delta2-pirazolinas que sejam racemicos e enanciomericamente puros
MXPA03001985A (es) Cristales novedosos de n-hidroxi-2 (s) -metil-5 -etoximetoxi-4 (s)-[n -(4-fenoxifenilcarbonil) amino] pentamida, proceso para su produccion y composiciones farmaceuticas que los contienen.